1- Comité Français de Lutte contre l'hypertension Artérielle (CFLHTA). Enquête FLAHS 2010 (French League Against Hypertension Survey [FLAHS]). Les traitements par les antihypertenseurs en France en 2010 ?
3- Mancia G, Laurent S, Agabiti-Rosei E et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Journal of Hypertension 2009; 27:2121-2158.
4- The NAVIGATOR Study Group. Effect of Valsartan on the Incidence of Diabetes and Cardiovascular Events. N Engl J Med 2010;362:1477-90.
6- Godet-Mardirossian H, Girerd X, Vernay M, Chamontin M, Katia Castetbon K, de Peretti C. Patterns of hypertension management in France (ENNS 2006–2007). Eur J Cardiovasc Prev Rehabil. 2011 Mar 30. [Epub ahead of print]
7- Messerli FH, Makani H, Benjo A, Romero J, Alviar C, Bangalore S. Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring: a meta-analysis of randomized trials. J Am Coll Cardiol. 2011;57(5):590-600.
8- Myers MG, Godwin M, Dawes M, Kiss A et al. Conventional versus automated measurement of blood pressure in primary care patients with systolic hypertension: randomised parallel design controlled trial. BMJ 2011;342:d286; doi:10.1136/bmj.d286
10- The ACCORD Study Group. Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus. N Engl J Med 2010;362:1575-85.
Mise au point
Prise en charge de la goutte en 2025
Mise au point
Le prurit
Mise au point
Les infiltrations en médecine générale
Mise au point
Diagnostic de la maladie d’Alzheimer en 2025